Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravascular Ultrasound Guiding Percutaneous Coronary Interventions in Complex Higher Risk-Indicated Patients

Sidonio Mesquita Viana1, Dai-Min Zhang1

  • 1Department of Cardiology, Sir Run Run Hospital, Nanjing Medical University, 211112 Nanjing, Jiangsu, China.

Reviews in Cardiovascular Medicine
|January 1, 2025
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IRF-1 Links Cytoskeletal Contraction With Inflammatory Response in mTOR-Inhibited Endothelial Cells.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Does plaque morphology truly not matter?

European heart journal·2022
Same author

mTOR contributes to endothelium-dependent vasorelaxation by promoting eNOS expression and preventing eNOS uncoupling.

Communications biology·2022
Same author

Identification of vital modules and genes associated with heart failure based on weighted gene coexpression network analysis.

ESC heart failure·2022
Same author

mTOR Inhibition Promotes Pneumonitis through Inducing Endothelial Contraction and Hyperpermeability.

American journal of respiratory cell and molecular biology·2021
Same author

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases.

Cardiology research and practice·2020

Intravascular ultrasound (IVUS) improves percutaneous coronary intervention (PCI) for high-risk patients. Ongoing trials and addressing current gaps will further optimize outcomes for complex indicated patients (CHIPs).

Area of Science:

  • Cardiovascular Medicine
  • Medical Imaging

Background:

  • Intravascular ultrasound (IVUS) significantly enhances percutaneous coronary intervention (PCI) for complex higher risk-indicated patients (CHIPs).
  • IVUS provides detailed insights into lesion characteristics and vessel structure, complementing traditional angiography.
  • It improves precision in stent placement and postprocedural care for high-risk individuals.

Purpose of the Study:

  • To comprehensively review the impact of IVUS on patient outcomes and procedural success in CHIPs.
  • To highlight the significance of ongoing clinical trials evaluating IVUS in PCI.
  • To identify and address persistent challenges, including standardized protocols and routine practice integration.

Main Methods:

  • Review of current literature and ongoing clinical trials on IVUS-guided PCI in CHIPs.
Keywords:
complex higher risk-indicated patientscoronary artery diseaseintravascular ultrasoundmajor adverse cardiovascular eventspercutaneous coronary intervention

Related Experiment Videos

  • Analysis of data concerning patient outcomes, procedural success rates, and long-term prognostic indicators.
  • Identification of gaps in current IVUS implementation and standardization.

    • Main Results:

    • IVUS demonstrates a pivotal role in optimizing procedural accuracy and clinical outcomes for high-risk patients.
    • Ongoing trials are expected to yield new findings on the benefits of IVUS in PCI.
    • Current challenges include lack of standardized protocols, cost, and limited integration into routine practice.

    Conclusions:

    • IVUS-guided PCI is a transformative approach for managing CHIPs, improving precision and outcomes.
    • Further research and standardization are crucial to overcome existing barriers and maximize IVUS benefits.
    • Addressing these gaps will enhance the widespread adoption and effectiveness of IVUS in high-risk cardiovascular interventions.